<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Hearing loss in children: Etiology
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Hearing loss in children: Etiology
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Hearing loss in children: Etiology
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard JH Smith, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Adrian Gooi, MD, FRCS(C)
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Glenn C Isaacson, MD, FAAP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 07, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hearing loss in the first years of life can cause delays in speech, language, and cognitive development [
         <a href="#rid1">
          1
         </a>
         ]. Speech and language delays secondary to hearing loss are often preventable [
         <a href="#rid2">
          2,3
         </a>
         ]. Thus, early identification of hearing loss, whether it is permanent (usually sensorineural) or temporary (usually conductive), is the key to a child's success with communication [
         <a href="#rid4">
          4-7
         </a>
         ].
        </p>
        <p>
         Clinically significant hearing loss occurs in approximately 1 to 2 per 1000 newborns and in 2 per 1000 young children. However, many children develop transient hearing loss related to middle ear infections during the period from birth to 11 years of age [
         <a href="#rid8">
          8
         </a>
         ]. Identifying the etiology of hearing loss, particularly if genetic, can inform medical care and genetic counseling, and it assists in the development of the optimal habilitation plan for the patient [
         <a href="#rid9">
          9,10
         </a>
         ].
        </p>
        <p>
         The etiology of hearing loss in children are reviewed here  (
         <a class="graphic graphic_table graphicRef119919" href="/z/d/graphic/119919.html" rel="external">
          table 1
         </a>
         ). The evaluation and treatment of hearing loss are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6298.html" rel="external">
          "Hearing loss in children: Treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3019185110">
         <span class="h1">
          DEFINITIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following terms are used throughout this topic:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Conductive hearing loss
         </strong>
         – Conductive hearing loss is caused by a problem of the outer or middle ear that interferes with conduction of sound to the inner ear. It can occur at any location from the outer ear (pinna, external auditory canal) to the stapes footplate and oval window. In children, conductive hearing loss is most often transient (eg, otitis media with effusion), but it can be permanent (eg, aural atresia or chronic adhesive otitis media). Causes of conductive hearing loss are described below. (See
         <a class="local">
          'Conductive hearing loss'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sensorineural hearing loss (SNHL)
         </strong>
         – SNHL is hearing loss resulting from damage, disease, or other disorders affecting the inner ear (eg, the cochlea) and/or the auditory nerve (cranial nerve VIII).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          SNHL due to disorders of the inner ear
         </strong>
         – Numerous conditions (congenital or acquired) are associated with SNHL. The causes are discussed below. (See
         <a class="local">
          'Sensorineural hearing loss'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Auditory neuropathy spectrum disorder (ANSD)
         </strong>
         – In ANSD (also called auditory neuropathy, neural synchrony disorder, neural dyssynchrony, and paradoxical hearing loss), the cochlea can detect sound, but there is a problem sending the signal to the brain. ANSD is characterized by normal otoacoustic emissions (suggesting normal outer hair cell function from the cochlea) but abnormal auditory brainstem responses. The abnormality may be anatomically located from the inner hair cells of cochlea to the cochlear nerve of cranial nerve VIII.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          "Retrocochlear" hearing loss
         </strong>
         – "Retrocochlear" refers to lesions proximal to the cochlea. We define "retrocochlear" hearing loss as hearing loss resulting from abnormalities of the eighth cranial nerve. The most common retrocochlear lesion is a vestibular schwannoma. However, there is overlap between retrocochlear hearing loss and ANSD, and the terms are used somewhat inconsistently in the medical literature. Some resources use the term "retrocochlear" more broadly to describe other abnormalities of the auditory central nervous system.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mixed hearing loss
         </strong>
         – Mixed hearing loss refers to a combination of conductive and sensorineural hearing loss.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic hearing loss
         </strong>
         – This term refers to hearing loss (usually bilateral SNHL) that is caused by a pathogenic genetic variant. Most genetic causes of hearing loss have an autosomal recessive inheritance pattern. Thus, affected children often do
         <strong>
          not
         </strong>
         have affected relatives. For this reason, we prefer the term "genetic hearing loss" for this category rather than the commonly used term "hereditary hearing loss." (See
         <a class="local">
          'Genetic'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          ANATOMY AND PHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The ear is divided into three anatomic segments  (
         <a class="graphic graphic_figure graphicRef57082 graphicRef75010" href="/z/d/graphic/57082.html" rel="external">
          figure 1A-B
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Outer ear, comprising the auricle and external auditory canal (EAC)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Middle ear, comprising the tympanic membrane, ossicles (malleus, incus, and stapes), and the middle ear space
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inner ear, comprising the cochlea, semicircular canals, vestibule, and internal auditory canal
        </p>
        <p>
        </p>
        <p>
         Anatomically, the auricle has a unique structure. It "catches" incoming sound waves and then funnels them down the EAC. Sound waves vibrate the tympanic membrane, causing motion of the ossicles that results in a movement of the stapes footplate. Movement of the stapes is transmitted to the inner ear fluid as a traveling wave that propagates around the two and one-half turns of the cochlea. Frequency-specific movement of the organ of Corti bends the stereocilia, causing depolarization of the inner and outer hair cells and creating electrical impulses transmitted via the auditory nerve to the brain. The brain organizes the information into what we perceive as complex sounds.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          CONDUCTIVE HEARING LOSS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Conductive hearing loss is caused by a mechanical problem of the outer or middle ear that interferes with conduction of sound to the inner ear. It can occur at any location from the outer ear (pinna, external auditory canal) to the stapes footplate and oval window. Examples include cerumen impaction, middle ear fluid, and ossicular chain fixation  (
         <a class="graphic graphic_table graphicRef119919" href="/z/d/graphic/119919.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Outer ear
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital anomalies, infections, and trauma to the outer ear can cause conductive hearing loss.
        </p>
        <p class="headingAnchor" id="H1687404">
         <span class="h3">
          Obstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         The EAC may be obstructed by cerumen or bony growths:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cerumen – This is the most common cause of EAC obstruction. Thus, it is important to clear the EAC of cerumen for accurate pediatric audiologic testing.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exostoses – Exostoses are benign broad-based osseous lesions often presenting after a history of chronic cold water exposure (eg, cold water swimming). These lesions are frequently multiple and bilateral, usually diagnosed in teenagers or young adults, and far more common in males.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Osteomas – Osteomas are benign solitary smooth-round osseous lesions occurring at the tympanosquamous and tympanomastoid suture lines inside the bony EAC. These lesions usually present in middle age, although they may also occur in children.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Otitis externa can lead to blockage of the EAC caused by the accumulation of debris, edema, or inflammation. Otitis externa can develop after local EAC trauma or if impacted cerumen becomes contaminated by bacteria (or occasionally fungi) after swimming, showering, or exposure to hot and humid conditions. The canal is often filled with squamous and purulent debris, and significant edema of the EAC occurs. The most common symptoms are otalgia (often severe), pruritus, discharge, and hearing loss. (See
         <a class="medical medical_review" href="/z/d/html/6866.html" rel="external">
          "External otitis: Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Trauma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Penetrating trauma to the EAC or meatus may cause mild to severe conductive hearing loss, depending upon the degree of EAC injury and occlusion.
        </p>
        <p class="headingAnchor" id="H2671058115">
         <span class="h3">
          Congenital malformations
         </span>
         <span class="headingEndMark">
          —
         </span>
         The external auditory canal (EAC) develops from the 8
         <sup>
          th
         </sup>
         to the 28
         <sup>
          th
         </sup>
         week of gestation. Problems can occur anytime during this developmental phase. Microtia, the absence or malformation of the auricle, may be associated with mild to moderate conductive hearing loss, whereas atresia or significant stenosis of the EAC causes moderate to maximal (60 decibels [dB]) conductive hearing loss. It is possible to have a normal auricle, but an atretic canal. Unilateral atresia or significant stenosis of the EAC is much more common than is bilateral atresia.
        </p>
        <p>
         Congenital abnormalities of the outer ear may occur in isolation or may be part of a broader clinical syndrome  (
         <a class="graphic graphic_table graphicRef115370" href="/z/d/graphic/115370.html" rel="external">
          table 2
         </a>
         ). Outer ear malformations are reviewed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6299.html" rel="external">
          "Congenital anomalies of the ear", section on 'Outer ear malformations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Middle ear
         </span>
         <span class="headingEndMark">
          —
         </span>
         Conductive hearing loss associated with the middle ear may be caused by infection, congenital anomalies, tympanic membrane perforation, or tumors.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute otitis media (AOM) is the most common childhood disorder associated with conductive hearing loss. By the age of three years, most children will experience at least one episode of AOM and many will have experienced at least three episodes. (See
         <a class="medical medical_review" href="/z/d/html/6021.html" rel="external">
          "Acute otitis media in children: Epidemiology, microbiology, and complications", section on 'Epidemiology'
         </a>
         .)
        </p>
        <p>
         Conductive hearing loss occurs in AOM because fluid filling the middle ear space prevents the tympanic membrane from vibrating adequately, thereby diminishing movement of the ossicular chain. The hearing loss persists as long as fluid fills the middle ear space. The median loss is 25 dB, which is similar to the degree of hearing loss associated with the use of ear plugs. (See
         <a class="medical medical_review" href="/z/d/html/6021.html" rel="external">
          "Acute otitis media in children: Epidemiology, microbiology, and complications", section on 'Hearing loss'
         </a>
         .)
        </p>
        <p>
         Despite adequate therapy, middle ear effusion persists in many patients, a condition called otitis media with effusion (OME) or serous otitis media. In most cases, OME resolves spontaneously over approximately six weeks. Some children, particularly those at risk for speech delays or learning problems, may benefit from tympanostomy tube placement. This issue is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5966.html" rel="external">
          "Otitis media with effusion (serous otitis media) in children: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/87008.html" rel="external">
          "Otitis media with effusion (serous otitis media) in children: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Tympanic membrane perforation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Conductive hearing loss caused by tympanic membrane perforation is common. The degree of conductive hearing loss depends upon the size and location of the perforation. Small perforations and those located in the anterior/inferior quadrant cause a lesser degree of conductive hearing loss. Near-total or posterior/superior quadrant perforations are more likely to cause significant hearing loss.
        </p>
        <p>
         Tympanic membrane perforations can be caused by many events, including blast injury, barotrauma, foreign body trauma, temporal bone fractures, ear infections, self-inflicted trauma from a cotton-tipped applicator or other object  (
         <a class="graphic graphic_picture graphicRef67932" href="/z/d/graphic/67932.html" rel="external">
          picture 1
         </a>
         ); or the hole may persist after tympanostomy tubes fall out. In a study of 602 children presenting to the emergency department with traumatic tympanic membrane perforation, more than one-half of the injuries occurred in children &lt;6 years old [
         <a href="#rid11">
          11
         </a>
         ]. Foreign bodies (especially cotton-tipped applicators) were the most common cause in children &lt;12 years old; whereas the leading cause in children 13 to 18 years old was water trauma (ie, from forced pressure of water to the head during diving or waterskiing, barotrauma [eg, scuba-related], or injury from otitis externa following swimming).
        </p>
        <p>
         After an acute perforation, the ear should be examined to ensure that the perforation heals without cholesteatoma formation. Documentation of a patient's auditory status also is mandatory for any newly-diagnosed perforation. (See
         <a class="medical medical_review" href="/z/d/html/6306.html" rel="external">
          "Cholesteatoma in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Trauma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blunt trauma can lead to temporal bone fracture, usually by a blow to the temporal parietal region  (
         <a class="graphic graphic_diagnosticimage graphicRef59595" href="/z/d/graphic/59595.html" rel="external">
          image 1
         </a>
         ). Hearing loss due to temporal bone fracture is typically conductive and associated with tympanic membrane perforations and blood in the middle ear space. Conductive hearing loss can occur with ossicular injury, typically due to separation of the incudostapedial joint and/or incus dislocation. Otic capsule fractures are more frequently associated with sensorineural hearing loss, facial nerve injury, or cerebrospinal fluid leak. (See
         <a class="local">
          'Sensorineural hearing loss'
         </a>
         below.)
        </p>
        <p>
         Evaluation and management of middle ear trauma is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6544.html" rel="external">
          "Evaluation and management of middle ear trauma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Tumors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Malignant tumors, such as squamous cell carcinoma and proliferative disorders, including Langerhans cell histiocytosis, can cause conductive hearing loss. However, these entities are relatively rare when compared with nonmalignant cholesteatoma or otosclerosis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cholesteatoma
         </strong>
         – Cholesteatoma is a benign growth of stratified, squamous epithelium filled with desquamated cells and keratin  (
         <a class="graphic graphic_picture graphicRef80406" href="/z/d/graphic/80406.html" rel="external">
          picture 2
         </a>
         ). As keratin desquamates from the epithelial lining of the sac, it gradually enlarges, with eventual erosion of the ossicular chain, mastoid air cells, and EAC. Formation of a cholesteatoma typically occurs after a retraction pocket has formed in the posterior/superior quadrant of the tympanic membrane, usually the result of poor Eustachian tube function. It may also occur after tympanic membrane trauma, such as a traumatic, inflammatory, or iatrogenic perforation. A small percentage of cholesteatomas are congenital and occur most commonly in the anterior superior portion of the middle ear space, where they appear as a whitish pearl behind an intact tympanic membrane. (See
         <a class="medical medical_review" href="/z/d/html/6306.html" rel="external">
          "Cholesteatoma in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Otosclerosis
         </strong>
         – Otosclerosis is an abnormality of bone remodeling that produces overgrowth of sclerotic, hypervascular bone. It has a predilection for the footplate of the stapes. As the overgrowth develops, stapes motion is impaired and ossicular vibrations are not effectively transmitted to the inner ear fluid. Conduction gradually becomes worse until a maximal conductive hearing loss of 60 dB is reached. In most affected patients, the conductive hearing loss progresses gradually over several decades and eventually includes a significant sensorineural component. Otosclerosis is uncommon in children and very rarely recognized in the first decade of life.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H856471071">
         <span class="h3">
          Congenital malformations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital malformations of the ossicles may cause conductive hearing loss. Ossicular and other middle ear malformations occur as part of syndromes (eg,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F154500&amp;token=tEpDslnpc0F0kICl%2Fz7sFdq7KW313yBvat27CnEqDw9GOUvwZSDpMo1gtEJ2PM9w&amp;TOPIC_ID=6308" target="_blank">
          Treacher Collins
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F113650&amp;token=tEpDslnpc0F0kICl%2Fz7sFeFrwBDjxb9nersO1%2BvrxP9BX8FK%2BsrNYDMSEQUxmyCR&amp;TOPIC_ID=6308" target="_blank">
          branchio-oto-renal
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F108300&amp;token=tEpDslnpc0F0kICl%2Fz7sFRc%2FQ%2FdLCs5TziGRc%2F5rLwhZbcurPGWxtgCxKYjUwhNT&amp;TOPIC_ID=6308" target="_blank">
          Stickler
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F192430&amp;token=tEpDslnpc0F0kICl%2Fz7sFQdsXnRDd5WxpnJNX2h2G8P%2BZTaa%2Fq6iwZl2Z8iqDnum&amp;TOPIC_ID=6308" target="_blank">
          velocardiofacial (DiGeorge)
         </a>
         ,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F130650&amp;token=tEpDslnpc0F0kICl%2Fz7sFc6jRLzqNN8gxZwGEOirhGkxIaK%2FRZdv2LrKgyNDqO3u&amp;TOPIC_ID=6308" target="_blank">
          Beckwith-Wiedemann
         </a>
         ) and, occasionally, as isolated events. They may or may not be associated with EAC stenosis and/or microtia.
        </p>
        <p>
         The most common abnormalities of the ossicles are fixation of the malleus and/or incus, incudostapedial discontinuity, and stapes fixation. These defects in the middle ear's conducting mechanism cause hearing losses ranging from minor to maximal (60 dB) and have important effects on communication and learning.
        </p>
        <p>
         Osteogenesis imperfecta is an autosomal dominant condition associated with fragile bones that fracture easily. Children with this disorder may develop ossicular dislocation, stapes fixation, or fracture of the ossicles, resulting in a conductive hearing loss. (See
         <a class="medical medical_review" href="/z/d/html/2943.html" rel="external">
          "Osteogenesis imperfecta: An overview"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          SENSORINEURAL HEARING LOSS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sensorineural hearing loss (SNHL) results from damage, disease, or other disorders affecting the inner ear (cochlea) and/or the auditory nerve. SNHL can be categorized as congenital (including both genetic and nongenetic causes) and acquired  (
         <a class="graphic graphic_table graphicRef119919" href="/z/d/graphic/119919.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Congenital
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital hearing loss is any hearing loss that is identified at or shortly after birth. It may be genetic or nongenetic. Nongenetic etiologies involve an insult to the developing cochlea, such as intrauterine infection, medications, or toxins that have a teratogenic effect on the developing ear of the fetus (eg, alcohol, methyl mercury,
         <a class="drug drug_pediatric" data-topicid="12756" href="/z/d/drug information/12756.html" rel="external">
          quinine
         </a>
         , trimethadione, retinoic acid, and maternal thyroid peroxidase autoantibodies) [
         <a href="#rid10">
          10,12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h3">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital infection caused by cytomegalovirus (CMV), toxoplasmosis, rubella, or syphilis is associated with SNHL. The hearing loss in these conditions frequently is progressive or delayed in onset, emphasizing the need for universal newborn hearing screening and continued monitoring of children with known congenital infections. (See
         <a class="medical medical_review" href="/z/d/html/2872.html" rel="external">
          "Screening tests in children and adolescents", section on 'Hearing screen'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4985.html" rel="external">
          "Screening the newborn for hearing loss"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital CMV infection (cCMV)
         </strong>
         – cCMV is the leading infectious cause of congenital SNHL [
         <a href="#rid13">
          13
         </a>
         ]. SNHL can occur in infants with overtly symptomatic infection (symptomatic cCMV) and in those who lack apparent symptoms (asymptomatic cCMV). CMV-associated hearing loss is highly variable and can be progressive or delayed and unilateral or bilateral. Early treatment with antiviral therapy has been shown to improve hearing outcomes for neonates with congenital CMV infection. This is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">
          "Congenital cytomegalovirus infection: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/98188.html" rel="external">
          "Congenital cytomegalovirus infection: Management and outcome", section on 'Antiviral treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Importantly, an isolated finding of hearing loss in an infant with otherwise asymptomatic congenital CMV infection
         <strong>
          does not
         </strong>
         exclude genetic causes of hearing loss, which should also be considered [
         <a href="#rid14">
          14
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation", section on 'Identifying the etiology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital toxoplasmosis
         </strong>
         – SNHL can occur in children with congenital toxoplasmosis, although the exact incidence is unclear [
         <a href="#rid15">
          15
         </a>
         ]. The hearing loss can be delayed and progressive [
         <a href="#rid16">
          16
         </a>
         ], and the hearing prognosis may be improved if the infection is diagnosed prenatally or shortly after birth and prompt treatment is provided [
         <a href="#rid15">
          15
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14426.html" rel="external">
          "Congenital toxoplasmosis: Clinical features and diagnosis", section on 'Clinical features'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15835.html" rel="external">
          "Congenital toxoplasmosis: Treatment, outcome, and prevention", section on 'Treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital rubella
         </strong>
         – Hearing loss affects 68 to 93 percent of children with congenital rubella. It is usually profound and bilateral and sometimes progressive [
         <a href="#rid10">
          10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6047.html" rel="external">
          "Congenital rubella"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital syphilis
         </strong>
         – SNHL is a late manifestation of congenital syphilis, typically developing suddenly at 8 to 10 years of age. The higher frequencies are affected first; normal conversational tones are affected later. SNHL in this setting is the result of inflammation from untreated disease and can be prevented by appropriate therapy before three months of age. (See
         <a class="medical medical_review" href="/z/d/html/14428.html" rel="external">
          "Congenital syphilis: Clinical manifestations, evaluation, and diagnosis", section on 'Late congenital syphilis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Congenital Zika virus infection
         </strong>
         – SNHL has been reported in 5 to 10 percent of infants with congenital Zika virus infection. SNHL occurs predominantly in infants with severe central nervous system involvement. (See
         <a class="medical medical_review" href="/z/d/html/109681.html" rel="external">
          "Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate", section on 'Clinical findings'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h3">
          Malformations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital malformations (dysplasias) of the inner ear cause SNHL. High-resolution computed tomographic and magnetic resonance imaging techniques can identify subtle variations in anatomy that may lead to variable degrees of hearing loss. Children with genetic SNHL have a high incidence of minor malformations of the semicircular canals, cochlea, and internal auditory canal. Inner ear malformation are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6299.html" rel="external">
          "Congenital anomalies of the ear", section on 'Inner ear malformations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h3">
          Perilymph fistula
         </span>
         <span class="headingEndMark">
          —
         </span>
         Perilymph fistula (PLF) is a leak of inner ear fluid through a defect in the otic capsule. Leaks at the round window membrane or the oval window annular ligament may occur. PLFs permit communication between the middle ear and the inner ear. They can be caused by trauma or by a congenital defect of the stapes footplate.
        </p>
        <p>
         PLF is uncommon and difficult to diagnose. Typical symptoms include fluctuating severe SNHL, dysequilibrium, and aural fullness. Exploratory surgery performed by an otolaryngologist may be necessary to provide a definite diagnosis and to repair the leak.
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h3">
          Genetic
         </span>
         <span class="headingEndMark">
          —
         </span>
         Genetic bilateral SNHL occurs in approximately 5 to 10 per 10,000 births [
         <a href="#rid8">
          8
         </a>
         ]. In developed countries, it accounts for 50 to 60 percent of cases of SNHL in children [
         <a href="#rid17">
          17
         </a>
         ]. Approximately one-third are syndromic (associated with other abnormalities  (
         <a class="graphic graphic_table graphicRef66758" href="/z/d/graphic/66758.html" rel="external">
          table 3
         </a>
         )) and two-thirds nonsyndromic [
         <a href="#rid18">
          18-20
         </a>
         ].
        </p>
        <p>
         The hearing deficit in genetic hearing loss may be present at birth (congenital), progressive from birth, or it may have onset later in childhood.
        </p>
        <p>
         Approximately 80 percent of cases of genetic hearing loss are inherited in an autosomal recessive pattern, 15 percent are autosomal dominant, 2 percent are X-linked (mainly recessive) [
         <a href="#rid21">
          21
         </a>
         ], and 1 percent are mitochondrial [
         <a href="#rid18">
          18
         </a>
         ]. A complete list is available on the
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fhereditaryhearingloss.org%2F&amp;token=45dXEgejU56J4367%2F0J2WG%2BcrOjdEdzKvYfmU37y9aYljyNoRmORh%2FbTKZ6UhCzb&amp;TOPIC_ID=6308" target="_blank">
          Hereditary Hearing Loss website
         </a>
         . Because genetic hearing loss is most often inherited as an autosomal recessive trait, many affected children do
         <strong>
          not
         </strong>
         have affected relatives.
        </p>
        <p>
         The identification of genetic causes of hearing loss has improved the understanding of the biology of hearing and deafness and has changed the evaluation of children with congenital hearing loss. Next to the audiogram, comprehensive genetic testing is now recognized as a critical tool in the diagnosis, evaluation, and management of the hearing-impaired child, particularly in children with bilateral SNHL [
         <a href="#rid22">
          22,23
         </a>
         ]. The approach to genetic testing in children with SNHL is reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation", section on 'Genetic testing'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3728776040">
         <span class="h4">
          Syndromic sensorineural hearing loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately one-third of children with genetic hearing loss have syndromes that are associated with other abnormalities  (
         <a class="graphic graphic_table graphicRef66758" href="/z/d/graphic/66758.html" rel="external">
          table 3
         </a>
         ). Some of the more common syndromes include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Syndromes with an
         <strong>
          autosomal recessive
         </strong>
         inheritance pattern:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F276900&amp;token=tEpDslnpc0F0kICl%2Fz7sFWdn73fzwsrnK0ZHvwqS9sbTbB0qdBSytB%2FzjgjI3BR0&amp;TOPIC_ID=6308" target="_blank">
          Usher syndrome
         </a>
         , a form of retinitis pigmentosa, which is associated with progressive vision loss (see
         <a class="medical medical_review" href="/z/d/html/6905.html" rel="external">
          "Retinitis pigmentosa: Clinical presentation and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F274600&amp;token=tEpDslnpc0F0kICl%2Fz7sFWdn73fzwsrnK0ZHvwqS9sadWd8wfnCTxJVygbAU0vb5&amp;TOPIC_ID=6308" target="_blank">
          Pendred syndrome
         </a>
         , in which SNHL is accompanied by thyroid disease or goiter
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Alport, which can have variable inheritance patterns and is associated with a family or personal history of kidney disease (see
         <a class="medical medical_review" href="/z/d/html/6093.html" rel="external">
          "Clinical manifestations, diagnosis, and treatment of Alport syndrome (hereditary nephritis)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Jervell-Lange-Nielsen syndrome (long QT syndrome with deafness) (see
         <a class="medical medical_review" href="/z/d/html/1036.html" rel="external">
          "Congenital long QT syndrome: Epidemiology and clinical manifestations"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Syndromes with an
         <strong>
          autosomal dominant
         </strong>
         inheritance pattern:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F193500&amp;token=tEpDslnpc0F0kICl%2Fz7sFQdsXnRDd5WxpnJNX2h2G8MIFKw%2FD76VLG2N9GQaTp5r&amp;TOPIC_ID=6308" target="_blank">
          Waardenburg syndrome
         </a>
         types I and II, which are associated with pigmentary abnormalities  (
         <a class="graphic graphic_picture graphicRef56776" href="/z/d/graphic/56776.html" rel="external">
          picture 3
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/3004.html" rel="external">
          "The genodermatoses: An overview", section on 'Waardenburg syndrome'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Alport (which can have variable inheritance patterns) or
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F113650&amp;token=tEpDslnpc0F0kICl%2Fz7sFeFrwBDjxb9nersO1%2BvrxP9BX8FK%2BsrNYDMSEQUxmyCR&amp;TOPIC_ID=6308" target="_blank">
          branchio-oto-renal syndrome
         </a>
         , both of which are associated with a family or personal history of kidney disease (see
         <a class="medical medical_review" href="/z/d/html/6093.html" rel="external">
          "Clinical manifestations, diagnosis, and treatment of Alport syndrome (hereditary nephritis)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neurofibromatosis I and II (see
         <a class="medical medical_review" href="/z/d/html/2939.html" rel="external">
          "Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5206.html" rel="external">
          "
          <i>
           NF2
          </i>
          -related schwannomatosis (formerly neurofibromatosis type 2)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Syndromes with an
         <strong>
          X-linked
         </strong>
         inheritance pattern:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Alport syndrome (which can have variable inheritance patterns) (see
         <a class="medical medical_review" href="/z/d/html/6093.html" rel="external">
          "Clinical manifestations, diagnosis, and treatment of Alport syndrome (hereditary nephritis)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hunter syndrome (mucopolysaccharidosis 2) (see
         <a class="medical medical_review" href="/z/d/html/2931.html" rel="external">
          "Mucopolysaccharidoses: Clinical features and diagnosis", section on 'MPS type II (Hunter syndrome)'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other syndromes that lack a clear or consistent inheritance pattern include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F214800&amp;token=tEpDslnpc0F0kICl%2Fz7sFZpszKvOtG3bo7mRUx02%2BlbEMbUG%2FLEfFXZcV%2B%2FeqSYV&amp;TOPIC_ID=6308" target="_blank">
          CHARGE syndrome
         </a>
         , which is associated with choanal atresia, colobomas, heart defects, intellectual disability, genital hypoplasia, and ear anomalies (see
         <a class="medical medical_review" href="/z/d/html/6299.html" rel="external">
          "Congenital anomalies of the ear", section on 'Ear anomalies in CHARGE and DiGeorge syndromes'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hemifacial microsomia, which is characterized by mandibular hypoplasia, orbital distortion, and ear anomalies (
         <a class="graphic graphic_picture graphicRef57724" href="/z/d/graphic/57724.html" rel="external">
          picture 4
         </a>
         ) (see
         <a class="medical medical_review" href="/z/d/html/2926.html" rel="external">
          "Syndromes with craniofacial abnormalities", section on 'Craniofacial microsomia'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mitochondrial disorders – Mitochondrial inheritance accounts for less than 1 percent of all genetic hearing loss. Transmission occurs through the maternal lineage. Hearing loss may be isolated or associated with other features of mitochondrial disorders such as lactic acidosis, encephalopathy, myopathy, seizures, ophthalmoplegia, diabetes mellitus, cardiomyopathy, stroke-like episodes, ataxia, and optic atrophy [
         <a href="#rid24">
          24
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6193.html" rel="external">
          "Approach to the metabolic myopathies"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Advances are being made in the understanding of the molecular biology of hearing [
         <a href="#rid25">
          25-29
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Autosomal recessive Alport syndrome is associated with mutations in the alpha-3 or alpha-4 chains of type IV collagen [
         <a href="#rid30">
          30
         </a>
         ]. The defect in hearing, as well as the associated renal disease, is caused by impaired formation of a unique type of collagen. (See
         <a class="medical medical_review" href="/z/d/html/6086.html" rel="external">
          "Genetics, pathogenesis, and pathology of Alport syndrome (hereditary nephritis)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The defect in Jervell-Lange-Nielsen syndrome, which typically presents with bilateral profound SNHL and long QT on electrocardiogram, involves potassium conductance and impaired endolymph production [
         <a href="#rid31">
          31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1009.html" rel="external">
          "Congenital long QT syndrome: Pathophysiology and genetics"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3885193963">
         <span class="h4">
          Nonsyndromic sensorineural hearing loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most children with genetic hearing loss (approximately two-thirds) have nonsyndromic hearing loss. The list of genes linked to nonsyndromic genetic hearing loss continues to expand and now includes well over 100 genes [
         <a href="#rid24">
          24,32
         </a>
         ]. The two genetic causes that are identified most commonly should be mentioned and include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.omim.org%2Fentry%2F121011&amp;token=G%2BkOOgscg7PQzd0gXq5S94aP98exJ8ANNg5g6Gz7T8xA0zYoC4laxr0x6kJV832t&amp;TOPIC_ID=6308" target="_blank">
          <i>
           GJB2
          </i>
         </a>
         – Mutations in the
         <em>
          GJB2
         </em>
         gene that encodes the protein connexin 26 (CX26) on chromosome 13 cause nearly one-half of all bilateral
         <strong>
          severe to profound
         </strong>
         congenital hearing loss in nonsyndromic children [
         <a href="#rid19">
          19,27,33,34
         </a>
         ]. Mutations in this gene are also an occasional cause of autosomal dominant hearing loss that is often associated with palmoplantar keratoderma [
         <a href="#rid35">
          35,36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2Fentry%2F606440&amp;token=87jLzclRwWxNoI%2BQq5Gg70cVn7ayZ%2FMLJ%2B5GnSoARkMnPKpjz%2BZwy3N%2Fs5AbAI4x&amp;TOPIC_ID=6308" target="_blank">
          <i>
           STRC
          </i>
         </a>
         <em>
         </em>
         – The most common cause of
         <strong>
          mild to moderate
         </strong>
         nonsyndromic recessive hearing loss is mutation of the
         <em>
          STRC
         </em>
         gene. This gene encodes the protein stereocilin, which is often deleted together with the neighboring gene,
         <em>
          CATSPER2
         </em>
         [
         <a href="#rid37">
          37
         </a>
         ]. Males deleted of both copies of
         <em>
          STRC
         </em>
         and
         <em>
          CATSPER2
         </em>
         have infertility as well as mild to moderate hearing loss; females only have hearing loss [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Both of these genetic causes of hearing loss typically show an autosomal recessive inheritance pattern. Other forms of nonsyndromic HHL can have an autosomal recessive or autosomal dominant inheritance pattern. X-link inheritance is uncommon, but at least five genes with this an X-linked pattern have been reported [
         <a href="#rid32">
          32,38
         </a>
         ]. Nonsyndromic autosomal dominant disorders that cause progressive SNHL may present with early onset (during the first decade of life) or delayed onset (during the second or third decade) [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
         A complete list of genes linked to genetic hearing loss is available on the
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fhereditaryhearingloss.org%2F&amp;token=45dXEgejU56J4367%2F0J2WG%2BcrOjdEdzKvYfmU37y9aYljyNoRmORh%2FbTKZ6UhCzb&amp;TOPIC_ID=6308" target="_blank">
          Hereditary Hearing Loss website
         </a>
         .
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h2">
          Acquired sensorineural hearing loss
         </span>
         <span class="headingEndMark">
          —
         </span>
         Causes of acquired SNHL include prematurity, infection, hyperbilirubinemia, ototoxins, noise, and tumors.
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h3">
          Prematurity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 0.5 to 2.4 percent of very low birth weight (&lt;1500 g) infants develop SNHL [
         <a href="#rid39">
          39,40
         </a>
         ]. The risk of hearing loss increases with decreasing birth weight and gestational age [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
         The high rate of hearing loss among preterm infants has been linked to several factors, including administration of ototoxic drugs, such as aminoglycoside antibiotics, ambient noise produced by the incubator [
         <a href="#rid41">
          41
         </a>
         ], and perinatal complications (eg, hypoxia, acidosis, and hyperbilirubinemia) [
         <a href="#rid42">
          42,43
         </a>
         ]. Continued improvements in obstetrical and newborn care have led to decreased mortality in premature infants. As further advances are made in this area, decreased mortality will pose an increased risk of developmental disabilities, including hearing loss, for premature and low birth weight babies [
         <a href="#rid44">
          44,45
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5005.html" rel="external">
          "Care of the neonatal intensive care unit graduate", section on 'Hearing'
         </a>
         .)
        </p>
        <p>
         Universal newborn hearing screening is recommended for all newborns, and this is particularly important in preterm neonates. Newborn hearing screening is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4985.html" rel="external">
          "Screening the newborn for hearing loss"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h3">
          Hyperbilirubinemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperbilirubinemia in newborns can result from isoimmune hemolytic disease (eg, ABO blood group incompatibility), enzymatic defects (eg, glucose-6-phosphate-dehydrogenase deficiency), sepsis, increased enterohepatic circulation (eg, breast milk jaundice), and numerous other causes that are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/5020.html" rel="external">
          "Unconjugated hyperbilirubinemia in neonates: Etiology and pathogenesis", section on 'Causes of significant unconjugated neonatal hyperbilirubinemia'
         </a>
         .)
        </p>
        <p>
         Severe hyperbilirubinemia can lead to SNHL because bilirubin is toxic to the cochlear nuclei and the auditory neural pathways (ie, auditory neuropathy). The risk of hearing loss is greatest in infants with hyperbilirubinemia above the threshold for exchange transfusion  (
         <a class="graphic graphic_figure graphicRef68219" href="/z/d/graphic/68219.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid46">
          46
         </a>
         ]. In one study of 100 neonates with severe hyperbilirubinemia (ie, at or above the threshold for exchange transfusion), 28 percent were found to have evidence of auditory toxicity [
         <a href="#rid47">
          47
         </a>
         ]. In addition, preterm infants with prolonged hyperbilirubinemia, particularly if it coincides with episodes of acidosis, appear to be at increased risk for SNHL [
         <a href="#rid48">
          48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4994.html" rel="external">
          "Unconjugated hyperbilirubinemia in neonates: Risk factors, clinical manifestations, and neurologic complications", section on 'Incidence'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h3">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bacterial meningitis is the most common cause of postnatally acquired deafness in childhood [
         <a href="#rid49">
          49,50
         </a>
         ]. The reported frequency of persistent hearing loss varies from 2.5 to 18 percent in survivors [
         <a href="#rid49">
          49-52
         </a>
         ]. Another 10 percent of children have transient hearing loss [
         <a href="#rid52">
          52
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6000.html" rel="external">
          "Bacterial meningitis in children: Neurologic complications"
         </a>
         .)
        </p>
        <p>
         SNHL occurs early in the course of bacterial meningitis (within the first 48 hours), with possible recovery or worsening during the first two weeks of illness [
         <a href="#rid53">
          53,54
         </a>
         ]. Permanent hearing loss may be caused by damage to the cochlea, labyrinth, or eighth cranial nerve from direct bacterial invasion or the inflammatory response elicited by the infection [
         <a href="#rid51">
          51,55
         </a>
         ]. Labyrinthitis detected by gadolinium-enhanced magnetic resonance imaging early in the course of disease is predictive of the development of SNHL [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         In some studies, treatment with
         <a class="drug drug_pediatric" data-topicid="13214" href="/z/d/drug information/13214.html" rel="external">
          dexamethasone
         </a>
         very early in the course of meningitis decreased the incidence of hearing loss and neurologic sequelae, especially when the causative pathogen was
         <em>
          Haemophilus influenzae
         </em>
         type b. Whether dexamethasone reduced the rate of hearing loss with other bacterial etiologies is less certain. This issue is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6026.html" rel="external">
          "Bacterial meningitis in children: Dexamethasone and other measures to prevent neurologic complications"
         </a>
         .)
        </p>
        <p>
         Children who have had bacterial meningitis should have a prompt and complete hearing evaluation initially and regular follow-up if the evaluation is abnormal. These children may be candidates for early cochlear implantation (before the onset of cochlear ossification). (See
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h3">
          Ototoxic drugs
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ototoxic drugs, such as aminoglycosides, high-dose intravenous loop diuretics, and chemotherapeutic agents, such as
         <a class="drug drug_pediatric" data-topicid="13162" href="/z/d/drug information/13162.html" rel="external">
          cisplatin
         </a>
         , can cause significant hearing loss [
         <a href="#rid57">
          57,58
         </a>
         ]. The hearing loss caused by antibiotic or chemotherapeutic agents usually begins at high frequencies. The hearing loss becomes more pronounced with continued use and may even continue to worsen after the drug is discontinued. SNHL associated with many of these drugs is permanent.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aminoglycosides
         </strong>
         – All aminoglycosides are ototoxic. Some are more vestibulotoxic than cochleotoxic. In addition, renal impairment may increase the chance of ototoxicity. The relative order of cochleotoxicity is
         <a class="drug drug_pediatric" data-topicid="13332" href="/z/d/drug information/13332.html" rel="external">
          gentamicin
         </a>
         &gt;
         <a class="drug drug_pediatric" data-topicid="12845" href="/z/d/drug information/12845.html" rel="external">
          tobramycin
         </a>
         &gt;
         <a class="drug drug_pediatric" data-topicid="12541" href="/z/d/drug information/12541.html" rel="external">
          amikacin
         </a>
         &gt;
         <a class="drug drug_pediatric" data-topicid="12634" href="/z/d/drug information/12634.html" rel="external">
          neomycin
         </a>
         . Individuals with mutations in some of the mitochondrial genes have a genetic predisposition to the development of ototoxicity when exposed to even small doses of aminoglycosides [
         <a href="#rid59">
          59-61
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7242.html" rel="external">
          "Pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Otoacoustic emissions, which reflect the functional status of the outer hair cells in the cochlea, are a sensitive measure of the early effects of aminoglycoside-induced injury to the peripheral auditory system [
         <a href="#rid62">
          62
         </a>
         ] and may be useful in monitoring cochlear function during ototoxic treatment. (See
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation", section on 'Otoacoustic emissions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other antibiotics
         </strong>
         – Other antibiotics that can cause ototoxicity include the macrolides (
         <a class="drug drug_pediatric" data-topicid="13276" href="/z/d/drug information/13276.html" rel="external">
          erythromycin
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13165" href="/z/d/drug information/13165.html" rel="external">
          clarithromycin
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="12937" href="/z/d/drug information/12937.html" rel="external">
          azithromycin
         </a>
         ),
         <a class="drug drug_pediatric" data-topicid="12874" href="/z/d/drug information/12874.html" rel="external">
          vancomycin
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="12830" href="/z/d/drug information/12830.html" rel="external">
          tetracycline
         </a>
         . These drugs may have a more pronounced ototoxic effect in patients with impaired renal function.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chemotherapeutic agents
         </strong>
         – Numerous chemotherapeutic agents can cause hearing loss. The most common ones are
         <a class="drug drug_pediatric" data-topicid="13162" href="/z/d/drug information/13162.html" rel="external">
          cisplatin
         </a>
         , 5-fluorouracil (5-FU),
         <a class="drug drug_pediatric" data-topicid="13088" href="/z/d/drug information/13088.html" rel="external">
          bleomycin
         </a>
         , and nitrogen mustard. Of these, the risk of clinically significant hearing loss is greatest with cisplatin, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2826.html" rel="external">
          "Overview of neurologic complications of platinum-based chemotherapy", section on 'Ototoxicity'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Salicylates
         </strong>
         –
         <a class="drug drug_pediatric" data-topicid="12829" href="/z/d/drug information/12829.html" rel="external">
          Aspirin
         </a>
         and other nonsteroidal antiinflammatory drugs can cause hearing loss that is reversible with discontinuation of the drug. The etiology is believed to be enzymatic inhibition, which occurs only at very high doses (eg, 6 to 8 g/day of aspirin).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other medications
         </strong>
         – Antimalarial medications, such as
         <a class="drug drug_pediatric" data-topicid="12756" href="/z/d/drug information/12756.html" rel="external">
          quinine
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="13147" href="/z/d/drug information/13147.html" rel="external">
          chloroquine
         </a>
         , can cause SNHL and tinnitus, but as with salicylates, these effects are usually reversible. High-dose intravenous loop diuretics are an additional cause of temporary hearing loss and tinnitus [
         <a href="#rid63">
          63
         </a>
         ]. The risk is increased if the patient is also receiving other ototoxins, such as an aminoglycoside [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h3">
          Noise exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Excessive noise exposure is the most common modifiable cause of hearing loss in children [
         <a href="#rid64">
          64
         </a>
         ]. In older children and adolescents, the most common exposure comes from excessive and prolonged exposure to loud noise through personal listening devices [
         <a href="#rid65">
          65,66
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence
         </strong>
         – In the United States, the estimated prevalence of noise-induced hearing loss (NIHL) among adolescents ages 12 to 19 years is approximately 15 to 20 percent [
         <a href="#rid67">
          67
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Type of hearing loss and mechanism
         </strong>
         – A typical audiogram of noise-induced SNHL is demonstrated in the figure  (
         <a class="graphic graphic_figure graphicRef67636" href="/z/d/graphic/67636.html" rel="external">
          figure 3
         </a>
         ). Prolonged exposure to hazardous noise levels causes maximum damage to high-frequency areas of the cochlea. It is usually most severe at 4000 Hz and improves at 8000 Hz. However, hearing at higher frequencies will decline over time.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The mechanism by which excessive noise induces hearing loss includes direct mechanical damage of cochlear structures and metabolic overload caused by overstimulation [
         <a href="#rid68">
          68
         </a>
         ]. Some potential metabolic effects are excess nitric oxide release, which can damage hair cells; generation of oxygen free radicals that become toxic to membranes; and low magnesium concentrations that weaken hair cells by reducing the concentration of intracellular calcium.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Another important consequence of noise exposure is that it can cause "hidden hearing loss" (ie, a deficit that is not apparent on a standard audiogram but that affects an individual's ability to extract meaning from sounds in the presence of background noise). Believed to be a synaptopathy, hidden hearing loss reflects defects in cochlear transmission of acoustic signals [
         <a href="#rid69">
          69,70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention
         </strong>
         – Patients and parents/caregivers should be counseled about safe listening practices and other steps to reduce the risk of NIHL [
         <a href="#rid64">
          64
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When using a personal listening device, the child should be able to hear when spoken to and they should take regular breaks from the device.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Parents/caregivers of young children should be counseled to avoid excessively noisy venues (eg, concerts with loud music, sporting events in loud stadiums, fireworks) or to use hearing protection (eg, earmuffs) at such events.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When using an infant "white noise" sleep machine, the device should be placed as far away from the infant as possible, played at a low volume, and used only for short periods of time [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adolescents employed in noisy workplaces should be counselled to use appropriate hearing protection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The Occupational Safety and Health Administration (OSHA) have established standards and guidelines for noise exposure in order to protect workers in the United States. These guidelines are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6844.html" rel="external">
          "Etiology of hearing loss in adults", section on 'Noise exposure'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, the standard limit used in occupational settings (85 dB over eight hours) does not mean that this is safe for young listeners. In particular, the OSHA standards are not applicable personal listening devices, since music differs from industrial noise spectrally and temporally [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A short blast of loud noise also can cause severe to profound SNHL, pain, or hyperacusis (loudness intolerance). This reaction usually involves exposure to noise greater than 120 to 155 dB (eg, an ambulance siren or a firecracker). Thus, hearing protection in the form of muffs or plugs is highly recommended any time a person is exposed to extremely loud noises.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H31">
         <span class="h3">
          Trauma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Trauma to the temporal bone usually causes sensorineural or mixed hearing loss. Both penetrating and blunt trauma can result in temporal bone fractures. Penetrating trauma is typically due to gunshot wounds and blunt trauma to blows to the occipital or frontal regions. Temporal bone fractures that violate the otic capsule may run through the inner ear and result in a "dead" ear  (
         <a class="graphic graphic_diagnosticimage graphicRef59595" href="/z/d/graphic/59595.html" rel="external">
          image 1
         </a>
         ). Blunt trauma also causes SNHL when concussive forces are exerted on the inner ear fluids, causing a shearing effect on the cochlear organ of Corti. (See
         <a class="medical medical_review" href="/z/d/html/6544.html" rel="external">
          "Evaluation and management of middle ear trauma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6563.html" rel="external">
          "Skull fractures in children: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H32">
         <span class="h3">
          Tumors
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common tumor that causes SNHL is a vestibular schwannoma (acoustic neuroma), which is rare in children except in those with
         <em>
          NF2
         </em>
         -related schwannomatosis (NF2). These benign tumors usually originate from the vestibular portion of the eighth cranial nerve. Acoustic neuromas associated with NF2 are typically bilateral and asymmetric [
         <a href="#rid73">
          73
         </a>
         ]. Other symptoms and signs include tinnitus, disequilibrium, dizziness, headaches, facial hyperesthesia, facial muscular twitching, and facial paresis/paralysis. (See
         <a class="medical medical_review" href="/z/d/html/5222.html" rel="external">
          "Vestibular schwannoma (acoustic neuroma)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28805698">
         <span class="h3">
          Heavy metals
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cadmium, mercury, and arsenic may have toxic effects on cochlear cells, and mercury exposure may cause delayed auditory brainstem evoked potentials [
         <a href="#rid74">
          74
         </a>
         ]. In addition, lead can have neurotoxic effects. In a series of 2535 adolescents aged 12 to 19 years, those with a blood lead level of ≥2 mcg/dL had a twofold increased odds of high-frequency hearing loss compared with those with a lead level &lt;1 mcg/dL [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1290408395">
         <span class="h1">
          CENTRAL AUDITORY DISORDERS
         </span>
        </p>
        <p class="headingAnchor" id="H2731950145">
         <span class="h2">
          Cortical deafness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cortical deafness refers to hearing loss associated with brain injury or disease. The abnormality may be due to global brain injury or lesions in areas involved in auditory neural processing, from the cochlear nucleus of the brainstem to the primary auditory complex in the temporal lobe of the brain. Patients with cortical deafness may have profound hearing loss despite having normal peripheral auditory systems.
        </p>
        <p class="headingAnchor" id="H1687470">
         <span class="h2">
          Central auditory processing disorder
         </span>
         <span class="headingEndMark">
          —
         </span>
         Central auditory processing disorder (CAPD) refers to inefficient and/or ineffective processing and utilization of auditory information by the central nervous system. CAPD may be clinically significant in that patients have normal hearing sensitivity yet have difficulty interpreting sounds in complex situations such as speech or with background noise. However, it is challenging to distinguish CAPD from other language and learning disabilities, and there is ongoing controversy as to whether CAPD truly represents a distinct clinical entity [
         <a href="#rid76">
          76,77
         </a>
         ]. There is considerable variation in criteria used to define and diagnose CAPD. The diagnosis cannot be made with audiologic testing alone and usually requires a battery of behavioral tests [
         <a href="#rid78">
          78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/616.html" rel="external">
          "Etiology of speech and language disorders in children", section on 'Central auditory processing disorder'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H866265739">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Importance
         </strong>
         – Clinically significant hearing loss is uncommon in newborns and young children. However, many children develop transient hearing loss related to ear infections during early childhood. Hearing loss in the first years of life can cause delays in speech, language, and cognitive development. The causes of hearing loss in infancy and childhood are diverse  (
         <a class="graphic graphic_table graphicRef119919" href="/z/d/graphic/119919.html" rel="external">
          table 1
         </a>
         ). Identifying the etiology of the hearing loss, particularly if genetic, can direct subsequent care, facilitate genetic counseling, and assist in the development of the optimal habilitation plan for the child. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ear anatomy
         </strong>
         – The ear is divided into three segments  (
         <a class="graphic graphic_figure graphicRef57082 graphicRef75010" href="/z/d/graphic/57082.html" rel="external">
          figure 1A-B
         </a>
         ) (see
         <a class="local">
          'Anatomy and physiology'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Outer ear, comprising the auricle and external auditory canal (EAC)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Middle ear, comprising the tympanic membrane, ossicles (malleus, incus, and stapes), and the middle ear space
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inner ear, comprising the cochlea, semicircular canals, vestibule, and internal auditory canal
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Conductive hearing loss
         </strong>
         – Conductive hearing loss is caused by mechanical problems of the outer or middle ear that interfere with conduction of sound to the inner ear. It can occur at any location from the outer ear (pinna, EAC) to the stapes footplate and oval window. Common examples include cerumen impaction, middle ear fluid, and ossicular chain fixation. Other causes are summarized in the table  (
         <a class="graphic graphic_table graphicRef119919" href="/z/d/graphic/119919.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Conductive hearing loss'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sensorineural hearing loss (SNHL)
         </strong>
         – SNHL results from damage, disease, or other disorders affecting the inner ear (eg, the cochlea) and/or the auditory nerve. SNHL can be categorized as congenital (including both genetic and nongenetic causes) and acquired (see
         <a class="local">
          'Sensorineural hearing loss'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Genetic causes account for 50 to 60 percent of cases of SNHL; approximately one-third are syndromic (associated with other abnormalities  (
         <a class="graphic graphic_table graphicRef66758" href="/z/d/graphic/66758.html" rel="external">
          table 3
         </a>
         )) and two-thirds nonsyndromic. The hearing deficit in genetic hearing loss may be present at birth (congenital), progressive from birth, or develop when the child is older. (See
         <a class="local">
          'Genetic'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nongenetic etiologies of congenital SNHL involve an insult to the developing cochlea, such as intrauterine infection, medications, or toxins that have a teratogenic effect on the developing ear of the fetus. (See
         <a class="local">
          'Congenital'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Causes of acquired SNHL include prematurity, infection, hyperbilirubinemia, ototoxins, excessive noise exposure, trauma, and tumors  (
         <a class="graphic graphic_table graphicRef119919" href="/z/d/graphic/119919.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Acquired sensorineural hearing loss'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Central auditory disorders
         </strong>
         – Central causes of hearing loss include cortical deafness (ie, deafness associated with brain injury) and central auditory processing disorder (CAPD). CAPD refers to inefficient and/or ineffective processing and utilization of auditory information by the central nervous system. There is considerable variation in criteria used to define and diagnose CAPD, and it is challenging to distinguish CAPD from other language and learning disabilities. (See
         <a class="local">
          'Central auditory disorders'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Kral A, O'Donoghue GM. Profound deafness in childhood. N Engl J Med 2010; 363:1438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL. Language of early- and later-identified children with hearing loss. Pediatrics 1998; 102:1161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Downs MP, Yoshinaga-Itano C. The efficacy of early identification and intervention for children with hearing impairment. Pediatr Clin North Am 1999; 46:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watkin P, McCann D, Law C, et al. Language ability in children with permanent hearing impairment: the influence of early management and family participation. Pediatrics 2007; 120:e694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vohr B, Jodoin-Krauzyk J, Tucker R, et al. Early language outcomes of early-identified infants with permanent hearing loss at 12 to 16 months of age. Pediatrics 2008; 122:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pimperton H, Kennedy CR. The impact of early identification of permanent childhood hearing impairment on speech and language outcomes. Arch Dis Child 2012; 97:648.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ching TYC, Dillon H, Button L, et al. Age at Intervention for Permanent Hearing Loss and 5-Year Language Outcomes. Pediatrics 2017; 140.
          </a>
         </li>
         <li class="breakAll">
          Northern JL, Downs MP. Hearing in children, 4th ed, Williams and Wilkins, Baltimore 1991.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erenberg A, Lemons J, Sia C, et al. Newborn and infant hearing loss: detection and intervention.American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998- 1999. Pediatrics 1999; 103:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roizen NJ. Etiology of hearing loss in children. Nongenetic causes. Pediatr Clin North Am 1999; 46:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carniol ET, Bresler A, Shaigany K, et al. Traumatic Tympanic Membrane Perforations Diagnosed in Emergency Departments. JAMA Otolaryngol Head Neck Surg 2018; 144:136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wasserman EE, Nelson K, Rose NR, et al. Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment. Am J Epidemiol 2008; 167:701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goderis J, De Leenheer E, Smets K, et al. Hearing loss and congenital CMV infection: a systematic review. Pediatrics 2014; 134:972.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peterson J, Nishimura C, Smith RJH. Genetic Testing for Congenital Bilateral Hearing Loss in the Context of Targeted Cytomegalovirus Screening. Laryngoscope 2020; 130:2714.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGee T, Wolters C, Stein L, et al. Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis. Otolaryngol Head Neck Surg 1992; 106:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strasnick B, Jacobson JT. Teratogenic hearing loss. J Am Acad Audiol 1995; 6:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheffield AM, Smith RJH. The Epidemiology of Deafness. Cold Spring Harb Perspect Med 2019; 9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tomaski SM, Grundfast KM. A stepwise approach to the diagnosis and treatment of hereditary hearing loss. Pediatr Clin North Am 1999; 46:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohn ES, Kelley PM, Fowler TW, et al. Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1). Pediatrics 1999; 103:546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker M, Bitner-Glindzicz M. Genetic investigations in childhood deafness. Arch Dis Child 2015; 100:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grundfast KM, Atwood JL, Chuong D. Genetics and molecular biology of deafness. Otolaryngol Clin North Am 1999; 32:1067.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liming BJ, Carter J, Cheng A, et al. International Pediatric Otolaryngology Group (IPOG) consensus recommendations: Hearing loss in the pediatric patient. Int J Pediatr Otorhinolaryngol 2016; 90:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alford RL, Arnos KS, Fox M, et al. American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss. Genet Med 2014; 16:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mhatre AN, Lalwani AK. Molecular genetics of deafness. Otolaryngol Clin North Am 1996; 29:421.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skvorak Giersch AB, Morton CC. Genetic causes of nonsyndromic hearing loss. Curr Opin Pediatr 1999; 11:551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith RJ, Van Camp G. Non-syndromic hearing impairment: gene linkage and cloning. Int J Pediatr Otorhinolaryngol 1999; 49 Suppl 1:S159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zelante L, Gasparini P, Estivill X, et al. Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet 1997; 6:1605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           del Castillo I, Villamar M, Moreno-Pelayo MA, et al. A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. N Engl J Med 2002; 346:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schraders M, Oostrik J, Huygen PL, et al. Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction. Am J Hum Genet 2010; 86:604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mochizuki T, Lemmink HH, Mariyama M, et al. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 1994; 8:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duggal P, Vesely MR, Wattanasirichaigoon D, et al. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. Circulation 1998; 97:142.
          </a>
         </li>
         <li class="breakAll">
          Hereditary Hearing Loss Homepage. 2020. Available at: http://hereditaryhearingloss.org/ (Accessed on February 16, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kenna MA, Wu BL, Cotanche DA, et al. Connexin 26 studies in patients with sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 2001; 127:1037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frei K, Ramsebner R, Lucas T, et al. GJB2 mutations in hearing impairment: identification of a broad clinical spectrum for improved genetic counseling. Laryngoscope 2005; 115:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denoyelle F, Weil D, Maw MA, et al. Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene. Hum Mol Genet 1997; 6:2173.
          </a>
         </li>
         <li class="breakAll">
          Rabionet R, Gasparini P, Estivill X. Connexins and deafness homepage. davinci.crg.es/deafness/ (Accessed on January 18, 2006).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sloan-Heggen CM, Bierer AO, Shearer AE, et al. Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss. Hum Genet 2016; 135:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pfister MH, Apaydin F, Turan O, et al. A second family with nonsyndromic sensorineural hearing loss linked to Xp21.2: refinement of the DFN4 locus within DMD. Genomics 1998; 53:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Naarden K, Decouflé P. Relative and attributable risks for moderate to profound bilateral sensorineural hearing impairment associated with lower birth weight in children 3 to 10 years old. Pediatrics 1999; 104:905.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Dommelen P, Verkerk PH, van Straaten HL, Dutch Neonatal Intensive Care Unit Neonatal Hearing Screening Working Group. Hearing loss by week of gestation and birth weight in very preterm neonates. J Pediatr 2015; 166:840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Douek E, Dodson HC, Bannister LH, et al. Effects of incubator noise on the cochlea of the newborn. Lancet 1976; 2:1110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Razi MS, Das VK. Effects of adverse perinatal events on hearing. Int J Pediatr Otorhinolaryngol 1994; 30:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cristobal R, Oghalai JS. Hearing loss in children with very low birth weight: current review of epidemiology and pathophysiology. Arch Dis Child Fetal Neonatal Ed 2008; 93:F462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ehrenhaft PM, Wagner JL, Herdman RC. Changing prognosis for very low birth weight infants. Obstet Gynecol 1989; 74:528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mervis CA, Decouflé P, Murphy CC, Yeargin-Allsopp M. Low birthweight and the risk for mental retardation later in childhood. Paediatr Perinat Epidemiol 1995; 9:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wickremasinghe AC, Risley RJ, Kuzniewicz MW, et al. Risk of Sensorineural Hearing Loss and Bilirubin Exchange Transfusion Thresholds. Pediatrics 2015; 136:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amin SB, Saluja S, Saili A, et al. Auditory toxicity in late preterm and term neonates with severe jaundice. Dev Med Child Neurol 2017; 59:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Vries LS, Lary S, Dubowitz LM. Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. Pediatrics 1985; 76:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortnum HM. Hearing impairment after bacterial meningitis: a review. Arch Dis Child 1992; 67:1128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortnum H, Davis A. Epidemiology of permanent childhood hearing impairment in Trent Region, 1985-1993. Br J Audiol 1997; 31:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dodge PR, Davis H, Feigin RD, et al. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 1984; 311:869.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richardson MP, Reid A, Tarlow MJ, Rudd PT. Hearing loss during bacterial meningitis. Arch Dis Child 1997; 76:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplan SL, Catlin FI, Weaver T, Feigin RD. Onset of hearing loss in children with bacterial meningitis. Pediatrics 1984; 73:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vienny H, Despland PA, Lütschg J, et al. Early diagnosis and evolution of deafness in childhood bacterial meningitis: a study using brainstem auditory evoked potentials. Pediatrics 1984; 73:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplan SL, Woods CR. Neurologic complications of bacterial meningitis in children. Curr Clin Top Infect Dis 1992; 12:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kopelovich JC, Germiller JA, Laury AM, et al. Early prediction of postmeningitic hearing loss in children using magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 2011; 137:441.
          </a>
         </li>
         <li class="breakAll">
          Bendush CL. Ototoxicity: Clinical considerations and comparative information. In: The aminoglycosides: Microbiology, clinical use and toxicology, Marcel Dekker, New York 1982. p.453.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robertson CM, Tyebkhan JM, Peliowski A, et al. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr 2006; 95:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993; 4:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casano RA, Johnson DF, Bykhovskaya Y, et al. Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications. Am J Otolaryngol 1999; 20:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDermott JH, Wolf J, Hoshitsuki K, et al. Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype. Clin Pharmacol Ther 2022; 111:366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stavroulaki P, Apostolopoulos N, Dinopoulou D, et al. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 1999; 50:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gallagher KL, Jones JK. Furosemide-induced ototoxicity. Ann Intern Med 1979; 91:744.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balk SJ, Bochner RE, Ramdhanie MA, et al. Preventing Excessive Noise Exposure in Infants, Children, and Adolescents. Pediatrics 2023; 152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hussain T, Chou C, Zettner E, et al. Early Indication of Noise-Induced Hearing Loss in Young Adult Users of Personal Listening Devices. Ann Otol Rhinol Laryngol 2018; 127:703.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang W, Zhao F, Guderley N, Manchaiah V. Daily music exposure dose and hearing problems using personal listening devices in adolescents and young adults: A systematic review. Int J Audiol 2016; 55:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henderson E, Testa MA, Hartnick C. Prevalence of noise-induced hearing-threshold shifts and hearing loss among US youths. Pediatrics 2011; 127:e39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prasher D. New strategies for prevention and treatment of noise-induced hearing loss. Lancet 1998; 352:1240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wan G, Corfas G. Transient auditory nerve demyelination as a new mechanism for hidden hearing loss. Nat Commun 2017; 8:14487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           C Kohrman D, Wan G, Cassinotti L, Corfas G. Hidden Hearing Loss: A Disorder with Multiple Etiologies and Mechanisms. Cold Spring Harb Perspect Med 2020; 10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hugh SC, Wolter NE, Propst EJ, et al. Infant sleep machines and hazardous sound pressure levels. Pediatrics 2014; 133:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith RJ, Bale JF Jr, White KR. Sensorineural hearing loss in children. Lancet 2005; 365:879.
          </a>
         </li>
         <li class="breakAll">
          Jackler RK. Acoustic neuroma. In: Neurotology, Jackler R, Brackman DE (Eds), Mosby, St. Louis 1994. p.729.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prasher D. Heavy metals and noise exposure: health effects. Noise Health 2009; 11:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shargorodsky J, Curhan SG, Henderson E, et al. Heavy metals exposure and hearing loss in US adolescents. Arch Otolaryngol Head Neck Surg 2011; 137:1183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeBonis DA. It Is Time to Rethink Central Auditory Processing Disorder Protocols for School-Aged Children. Am J Audiol 2015; 24:124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore DR. The diagnosis and management of auditory processing disorder. Lang Speech Hear Serv Sch 2011; 42:303.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Audiology Clinical Practice Guidelines: Diagnosis, Treatment
and Management of Children and Adults with Central Auditory Processing Disorder (2010). Available at: https://www.audiology.org/publications-resources/document-library/central-auditory-processing-disorder (Accessed on December 11, 2018).
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6308 Version 39.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20925546" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Profound deafness in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9794949" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Language of early- and later-identified children with hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10079791" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The efficacy of early identification and intervention for children with hearing impairment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17766510" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Language ability in children with permanent hearing impairment: the influence of early management and family participation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18762523" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Early language outcomes of early-identified infants with permanent hearing loss at 12 to 16 months of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22550319" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The impact of early identification of permanent childhood hearing impairment on speech and language outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28864712" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Age at Intervention for Permanent Hearing Loss and 5-Year Language Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28864712" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Age at Intervention for Permanent Hearing Loss and 5-Year Language Outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9925859" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Newborn and infant hearing loss: detection and intervention.American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998- 1999.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10079789" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Etiology of hearing loss in children. Nongenetic causes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29270620" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Traumatic Tympanic Membrane Perforations Diagnosed in Emergency Departments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18156602" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25349318" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Hearing loss and congenital CMV infection: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31985074" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Genetic Testing for Congenital Bilateral Hearing Loss in the Context of Targeted Cytomegalovirus Screening.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1734373" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Absence of sensorineural hearing loss in treated infants and children with congenital toxoplasmosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7696676" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Teratogenic hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30249598" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The Epidemiology of Deafness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10079788" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : A stepwise approach to the diagnosis and treatment of hereditary hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10049954" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25324569" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Genetic investigations in childhood deafness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10523453" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Genetics and molecular biology of deafness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27729144" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : International Pediatric Otolaryngology Group (IPOG) consensus recommendations: Hearing loss in the pediatric patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24651602" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8743341" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Molecular genetics of deafness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10590915" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Genetic causes of nonsyndromic hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10577797" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Non-syndromic hearing impairment: gene linkage and cloning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9285800" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11807148" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : A deletion involving the connexin 30 gene in nonsyndromic hearing impairment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20346435" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7987396" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9445165" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9445165" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11556849" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Connexin 26 studies in patients with sensorineural hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15744158" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : GJB2 mutations in hearing impairment: identification of a broad clinical spectrum for improved genetic counseling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9336442" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9336442" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26969326" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9799605" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : A second family with nonsyndromic sensorineural hearing loss linked to Xp21.2: refinement of the DFN4 locus within DMD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10506233" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Relative and attributable risks for moderate to profound bilateral sensorineural hearing impairment associated with lower birth weight in children 3 to 10 years old.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25661409" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Hearing loss by week of gestation and birth weight in very preterm neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/62949" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Effects of incubator noise on the cochlea of the newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8045692" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Effects of adverse perinatal events on hearing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18941031" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Hearing loss in children with very low birth weight: current review of epidemiology and pathophysiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2668826" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Changing prognosis for very low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8570470" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Low birthweight and the risk for mental retardation later in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26283777" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Risk of Sensorineural Hearing Loss and Bilirubin Exchange Transfusion Thresholds.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27718221" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Auditory toxicity in late preterm and term neonates with severe jaundice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4034295" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1417060" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Hearing impairment after bacterial meningitis: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9478287" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Epidemiology of permanent childhood hearing impairment in Trent Region, 1985-1993.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6472398" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9068303" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Hearing loss during bacterial meningitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6718111" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Onset of hearing loss in children with bacterial meningitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6718112" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Early diagnosis and evolution of deafness in childhood bacterial meningitis: a study using brainstem auditory evoked potentials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1353677" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Neurologic complications of bacterial meningitis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21339394" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Early prediction of postmeningitic hearing loss in children using magnetic resonance imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21339394" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Early prediction of postmeningitic hearing loss in children using magnetic resonance imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16449030" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7689389" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10326749" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34032273" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10595663" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/496112" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Furosemide-induced ototoxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37864407" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Preventing Excessive Noise Exposure in Infants, Children, and Adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30056742" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Early Indication of Noise-Induced Hearing Loss in Young Adult Users of Personal Listening Devices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26768911" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Daily music exposure dose and hearing problems using personal listening devices in adolescents and young adults: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21187306" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Prevalence of noise-induced hearing-threshold shifts and hearing loss among US youths.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9788450" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : New strategies for prevention and treatment of noise-induced hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28211470" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Transient auditory nerve demyelination as a new mechanism for hidden hearing loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30617057" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Hidden Hearing Loss: A Disorder with Multiple Etiologies and Mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24590753" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Infant sleep machines and hazardous sound pressure levels.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15752533" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Sensorineural hearing loss in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15752533" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Sensorineural hearing loss in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19602766" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Heavy metals and noise exposure: health effects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22183895" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Heavy metals exposure and hearing loss in US adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25652246" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : It Is Time to Rethink Central Auditory Processing Disorder Protocols for School-Aged Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21757566" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : The diagnosis and management of auditory processing disorder.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
